Leveraged Commentary and Data’s (LCD) credit data, news, and research are now on PitchBook.
Learn more »
Latest Deal Type
Latest Deal Amount
Immunethep General Information
Operator of a biotechnology company intended to develop bacterial immunotherapies based on the discovery of a virulence mechanism shared by different bacteria that cause life-threatening infections. The company offers therapies including the development of neonatal vaccines to protect neonates from bacterial infections inside the mother's womb. thereby enabling patients to develop their immunity and prevent multi-bacterial infections and diseases through advanced healthcare methods.